-- Products: JAMP-Clopidogrel 75 mg and AG-Clopidogrel 75 mg tablets -- Issue: Health products -- Product safety -- What to do: If you are taking the affected products, speak with your pharmacist as ...
Golden State Medical Supply, Inc. has voluntarily recalled 1 lot of Clopidogrel 75mg Tablets and 1 lot of Atenolol 25mg Tablets due to a report stating that a bottle containing Clopidogrel 75mg ...
Plavix Clopidogrel buy plavix 75 mg advisable to prevent blood clots after a recent heart attack or allergy. It is also important by patients with certain disorders of the incidence or blood vessels.
After a suspected transient ischemic attack, an 81-year-old man who takes 81 mg aspirin daily was placed on clopidogrel (Plavix) 75 mg. Shortly thereafter, he developed easy bruising. Should I reduce ...
Clopidogrel (Aplatin 75) is an anti-platelet agent, that is, a drug that inhibits the ability of platelets to clump together as part of a blood clot. Clopidogrel (Aplatin 75) is prescribed either ...
Diminished antiplatelet effect in patients with two loss-of-function alleles of the CYP2C19 gene. Increased risk of bleeding. Premature discontinuation increases risk of cardiovascular events; if ...
Golden State Medical Supply, Incorporated (GSMS, Inc.) - Camarillo, CA has initiated a voluntary recall of the products listed in the table below because a report was received that a bottle containing ...
Bottles of medication designed to keep blood pressure down contained medication designed to help prevent strokes and blood clots in people with heart conditions, causing a recall of one lot of each.
Clopidogrel (Deplatt (150 mg)) is an anti-platelet agent, that is, a drug that inhibits the ability of platelets to clump together as part of a blood clot. Clopidogrel (Deplatt (150 mg)) is prescribed ...
Bridgewater/Princeton, NJ-The US FDA has approved a new 300-mg tablet of clopidogrel (Plavix, Sanofi-Aventis/Bristol-Myers Squibb) for use as a loading dose in acute ...
Dual antiplatelet therapy with clopidogrel plus low-dose aspirin has not been studied in a broad population of patients at high risk for atherothrombotic events. We randomly assigned 15,603 patients ...